United States· US:71288-712_c603acf5-af33-479a-8986-fbceb96ff1e5

Cisatracurium Besylate

A cisatracurium product containing cisatracurium besylate, registered in United States by Meitheal Pharmaceuticals Inc.. The same ATC class is registered in 15 of our 19 countries.

ATC M03AC11US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cisatracurium besylateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cisatracurium is registered in 15 of 19 countries.

Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
8 of them publish a price we can compare per daily dose

Search cisatracurium products by name

Cisatracurium · ATC M03AC11

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: CISATRACURIUM BESYLATE
Manufacturer: Meitheal Pharmaceuticals Inc.
Country: United States (US)
ATC code: M03AC11
ATC class: Cisatracurium
Defined daily dose: 10.5 mg, P
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
7128871296
10 VIAL, SINGLE-DOSE in 1 CARTON (71288-712-96) / 5 mL in 1 VIAL, SINGLE-DOSE (71288-712-95)
ndc11
71288-712-96

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for cisatracurium.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cisatracurium against other medicines How interaction checks work

Cisatracurium · interactions on record

89 records

12 severe
44 moderate
4 minor
29 info

Most severe, free to view

NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe
ParomomycinA07AA06severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cisatracurium in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cisatracurium products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
Belgium · Cisatracurium Fresenius Kabi, Cisatracurium Hikma
Cyprus · Cisatracurium Accordpharma, Cisatral
Czechia · Cisatracurium Kabi, Cisatracurium Kalceks
Germany · Cisatracurium Hameln, Cisatracurium Hikma
Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
Estonia · Cisatracurium Kalceks
Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
France · Cisatracurium Accord, Cisatracurium Accordpharma
United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
Greece · Cisatral
Croatia · Cisatrakurij Accordpharma
Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
Italy · Cisatracurio Hikma, Cisatracurio Kalceks
Lithuania · Cisatracurium Kalceks
Luxembourg · Nimbex
Latvia · Cisatracurium Kalceks
Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
Norway · Cisatracurium Accordpharma, Cisatracurium Kalceks
Poland · Cisatracurium Accordpharma, Cisatracurium Kabi
Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
Romania · Cisatracurium Noridem
Sweden · Cisatracurium Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ea4c6033-e77d-4fc9-b391-4c778ed0fe08
GET /v1/drugs/ea4c6033-e77d-4fc9-b391-4c778ed0fe08?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "10",
  "substance": "CISATRACURIUM BESYLATE",
  "productndc": "71288-712",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/5mL",
  "application_number": "ANDA211668",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about cisatracurium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console